Javascript must be enabled to continue!
Association of clopidogrel resistance with ethnicity in Pakistan.
View through CrossRef
Objective: The objective of this study was to assess relationship between clopidogrel resistance and different ethnicities in Pakistan. Study Design: Cross-sectional study. Setting: Army Medical College, National University of Medical Sciences (NUMS), Pakistan. Period: 2015 to 2019. Material & Methods: Included 390 ischemic heart disease (IHD) patients on clopidogrel therapy belonging to different ethnicities in Pakistan. Their platelet aggregation was assessed through light transmission aggregometry and the patients were divided into clopidogrel responder and clopidogrel resistant groups. Chi square analysis was done to assess difference in clopidogrel resistance among different ethnicities. One-way ANOVA was applied to assess difference in mean platelet aggregation among different ethnic groups. Results: This study has demonstrated that there was no significant difference in clopidogrel resistance among ischemic heart disease patients belonging to different ethnic groups of Pakistan, p = 0.566. Mean platelet aggregation of all the ethnic groups was also similar, p = 0.330. Conclusion: There is no association of clopidogrel resistance with ethnicity in Pakistan.
Independent Medical Trust
Title: Association of clopidogrel resistance with ethnicity in Pakistan.
Description:
Objective: The objective of this study was to assess relationship between clopidogrel resistance and different ethnicities in Pakistan.
Study Design: Cross-sectional study.
Setting: Army Medical College, National University of Medical Sciences (NUMS), Pakistan.
Period: 2015 to 2019.
Material & Methods: Included 390 ischemic heart disease (IHD) patients on clopidogrel therapy belonging to different ethnicities in Pakistan.
Their platelet aggregation was assessed through light transmission aggregometry and the patients were divided into clopidogrel responder and clopidogrel resistant groups.
Chi square analysis was done to assess difference in clopidogrel resistance among different ethnicities.
One-way ANOVA was applied to assess difference in mean platelet aggregation among different ethnic groups.
Results: This study has demonstrated that there was no significant difference in clopidogrel resistance among ischemic heart disease patients belonging to different ethnic groups of Pakistan, p = 0.
566.
Mean platelet aggregation of all the ethnic groups was also similar, p = 0.
330.
Conclusion: There is no association of clopidogrel resistance with ethnicity in Pakistan.
Related Results
Clopidogrel
Clopidogrel
Clopidogrel, a thienopyridine derivative, is a novel platelet antagonist that is several times more potent than ticlopidine but associated with fewer adverse effects. After repeate...
Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance
Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance
Objectives: To find out the prevalence of CYP2C19*2 genetic polymorphism in ischemic heart disease patients, and to determine its relation with clopidogrel resistance in different ...
ASSA13-11-4 The Clinical Application of VerifyNow-P2Y12 Assay in Evaluation of Platelet Inhibition with Clopidogrel
ASSA13-11-4 The Clinical Application of VerifyNow-P2Y12 Assay in Evaluation of Platelet Inhibition with Clopidogrel
Objective
To evaluate the platelet inhibition with VerifyNow-P2Y12 assay in patients under regular maintenance dose of Clopidogrel, and explore the clinical chara...
Clopidogrel response variability and its correlation with recurrent cardiovascular events in Chinese patients undergoing percutaneous coronary intervention
Clopidogrel response variability and its correlation with recurrent cardiovascular events in Chinese patients undergoing percutaneous coronary intervention
Objective
The present study was designed to explore response variability and its correlation with recurrent cardiovascular events in Chinese patients undergoing P...
Understanding clopidogrel resistance: Mechanisms, detections, implications and surmount the clopidogrel resistant in order to potential solutions
Understanding clopidogrel resistance: Mechanisms, detections, implications and surmount the clopidogrel resistant in order to potential solutions
Clopidogrel, a drug belonging to the thienopyridine class of antiplatelet agents, has been utilized either as a standalone medication or in combination with aspirin for averting va...
P258 Pharmacometabolomics analysis of plasma and urine to identify clopidogrel exposure metabolic biomarkers
P258 Pharmacometabolomics analysis of plasma and urine to identify clopidogrel exposure metabolic biomarkers
Abstract
Funding Acknowledgements
This research was funded by Universiti Sains Malaysia
...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Clopidogrel for Cerebrovascular Prevention
Clopidogrel for Cerebrovascular Prevention
Ischemic stroke, myocardial infarction and peripheral arterial disease are different clinical manifestations commonly due to the same underlying disease, i.e. atherosclerosis with ...

